Note: This document contains side effect information about peginesatide. Some dosage forms listed on this page may not apply to the brand name Omontys.

Applies to peginesatide: injectable solution.

Cardiovascular

Cardiovascular side effects have included hypotension (14.2%), hypertension (13.2%), and procedural hypotension (10.9%).^[Ref]

Gastrointestinal

Gastrointestinal side effects have included diarrhea (18.4%), nausea (17.4%), and vomiting (15.3%).^[Ref]

General

General side effects have included pyrexia (12.2%).^[Ref]

Immunologic

Immunologic side effects have included the development of peginesatide (the active ingredient contained in Omontys) specific antibodies (1.2%).^[Ref]

Metabolic

Metabolic side effects have included hyperkalemia (11.4%).^[Ref]

Musculoskeletal

Musculoskeletal side effects have included muscle spasms (15.3%), pain in extremity (10.9%), back pain (10.9%), and arthralgia (10.7%).^[Ref]

Nervous system

Nervous system side effects have included headache (15.4%).^[Ref]

Other

Other side effects have included arteriovenous fistula site complication (16.1%).^[Ref]

Respiratory

Respiratory side effects have included dyspnea (18.4%), cough (15.9%), and upper respiratory infection (11.0%).^[Ref]

Hypersensitivity

Hypersensitivity side effects have included postmarketing reports of serious allergic reactions including fatal reactions (0.02%).